ProCE Banner Activity

Rapid Antiretroviral Therapy Initiation: New Data and Ongoing Progress in China

Clinical Thought

At IDWeek 2022, investigators reported new findings from a long-term analysis of the randomized START trial comparing immediate vs delayed ART initiation. The results continue to reinforce the benefits of early vs later ART start and also support strategies in China that have successfully decreased time to ART initiation among newly diagnosed individuals.

Released: November 22, 2022

Share

Faculty

Yan Zhao

Yan Zhao, MD

Professor
Division of HIV/AIDS Treatment and Care
National Center for AIDS/STD Control and Prevention
Beijing, China

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Yan Zhao, MD

Professor
Division of HIV/AIDS Treatment and Care
National Center for AIDS/STD Control and Prevention
Beijing, China

Yan Zhao, MD, has no relevant financial disclosures to disclose.